Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation

  • Alon Kedem
  • Gil M. Yerushalmi
  • Masha Brengauz
  • Hila Raanani
  • Raoul Orvieto
  • Ariel Hourvitz
  • Dror Meirow
Fertility Preservation
  • 81 Downloads

Abstract

Purpose

Few clinical options for fertility preservation are available to females with cancer, and data about clinical outcomes is limited. Potential supplementary approaches to fertility preservation include retrieval of immature oocytes followed by in vitro maturation (IVM) and storage. The aim of this study was to evaluate post-thawing outcomes of immature oocytes collected both by transvaginal aspiration and from excised ovarian tissue.

Methods

We conducted a retrospective cohort study of patients treated in a single tertiary center. We reviewed the records of 119 cancer patients who underwent ovarian tissue cryopreservation and immature oocyte harvesting for fertility preservation. All embryos and oocytes that were frozen and thawed were included in the study. Post-thawing outcomes were evaluated.

Results

Thirty-five stored embryos from eight patients were thawed. Twenty-nine embryos survived (82% survival rate) and were transferred. Six oocytes were thawed, two oocytes survived, and no oocytes were fertilized. Only one PCOS patient became pregnant, resulting in the normal delivery of a healthy baby.

Conclusions

Although a relatively high number of mature oocytes and embryos can be stored with the combined procedure, the limited rate of pregnancies represents a poor reproductive outcome. Therefore, this approach should be reserved for special groups with limited options.

Keywords

Fertility preservation Oocyte retrieval In vitro oocyte maturation 

Notes

Availability of data and materials

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.

Conflict of interest

The authors declare that they have no competing interests.

References

  1. 1.
    Cvancarova M, Samuelsen SO, Magelssen H, Fossa SD. Reproduction rates after cancer treatment: experience from the Norwegian radium hospital. J Clin Oncol. 2009;27(3):334–43.  https://doi.org/10.1200/JCO.2007.15.3130.CrossRefPubMedGoogle Scholar
  2. 2.
    Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the childhood cancer survivor study. Am J Obstet Gynecol. 2002;187(4):1070–80.CrossRefPubMedGoogle Scholar
  3. 3.
    Magelssen H, Melve KK, Skjaerven R, Fossa SD. Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood. Hum Reprod. 2008;23(1):178–86.  https://doi.org/10.1093/humrep/dem362.CrossRefPubMedGoogle Scholar
  4. 4.
    Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the childhood cancer survivor study cohort. Lancet Oncol. 2013;14(9):873–81.  https://doi.org/10.1016/s1470-2045(13)70251-1.CrossRefPubMedGoogle Scholar
  5. 5.
    Society for Assisted Reproductive Technology, 2014 Clinic summary report. 2014. https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?ClinicPKID=0. Accessed 14/09/2017 2017.
  6. 6.
    Practice Committees of American Society for Reproductive M, Society for Assisted Reproductive T. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99(1):37–43.  https://doi.org/10.1016/j.fertnstert.2012.09.028.CrossRefGoogle Scholar
  7. 7.
    Meirow D. Fertility preservation in cancer patients using stored ovarian tissue: clinical aspects. Curr Opin Endocrinol Diabetes Obes. 2008;15(6):536–47.  https://doi.org/10.1097/MED.0b013e32831a44a8.CrossRefPubMedGoogle Scholar
  8. 8.
    Rodriguez-Wallberg KA, Oktay K. Options on fertility preservation in female cancer patients. Cancer Treat Rev. 2012;38(5):354–61.  https://doi.org/10.1016/j.ctrv.2011.10.002.CrossRefPubMedGoogle Scholar
  9. 9.
    Donnez J, Jadoul P, Squifflet J, Van Langendonckt A, Donnez O, Van Eyck AS, et al. Ovarian tissue cryopreservation and transplantation in cancer patients. Best Pract Res Clin Obstet Gynaecol. 2010;24(1):87–100.  https://doi.org/10.1016/j.bpobgyn.2009.09.003.CrossRefPubMedGoogle Scholar
  10. 10.
    Silber S, Kagawa N, Kuwayama M, Gosden R. Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril. 2010;94(6):2191–6.  https://doi.org/10.1016/j.fertnstert.2009.12.073.CrossRefPubMedGoogle Scholar
  11. 11.
    Donnez J, Dolmans MM, Pellicer A, Diaz-Garcia C, Sanchez Serrano M, Schmidt KT, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013;99(6):1503–13.  https://doi.org/10.1016/j.fertnstert.2013.03.030.CrossRefPubMedGoogle Scholar
  12. 12.
    Donnez J, Silber S, Andersen CY, Demeestere I, Piver P, Meirow D, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med. 2011;43(6):437–50.  https://doi.org/10.3109/07853890.2010.546807.CrossRefPubMedGoogle Scholar
  13. 13.
    Martinez F. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Fertil Steril. 2017;108(3):407–15.e11.  https://doi.org/10.1016/j.fertnstert.2017.05.024.CrossRefPubMedGoogle Scholar
  14. 14.
    Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra'anani H, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod. 2008;23(5):1007–13.  https://doi.org/10.1093/humrep/den055.CrossRefPubMedGoogle Scholar
  15. 15.
    Fasano G, Moffa F, Dechene J, Englert Y, Demeestere I. Vitrification of in vitro matured oocytes collected from antral follicles at the time of ovarian tissue cryopreservation. Reprod Biol Endocrinol. 2011;9:150.  https://doi.org/10.1186/1477-7827-9-150.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Hourvitz A, Yerushalmi GM, Maman E, Raanani H, Elizur S, Brengauz M, et al. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield. Reprod BioMed Online. 2015;31(4):497–505.  https://doi.org/10.1016/j.rbmo.2015.06.025.CrossRefPubMedGoogle Scholar
  17. 17.
    Revel A, Revel-Vilk S, Aizenman E, Porat-Katz A, Safran A, Ben-Meir A, et al. At what age can human oocytes be obtained? Fertil Steril. 2009;92(2):458–63.  https://doi.org/10.1016/j.fertnstert.2008.07.013.CrossRefPubMedGoogle Scholar
  18. 18.
    Prasath EB, Chan ML, Wong WH, Lim CJ, Tharmalingam MD, Hendricks M, et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod. 2014;29(2):276–8.  https://doi.org/10.1093/humrep/det420.CrossRefPubMedGoogle Scholar
  19. 19.
    Segers I, Mateizel I, Van Moer E, Smitz J, Tournaye H, Verheyen G, et al. In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising “ex vivo” method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe. J Assist Reprod Genet. 2015;32(8):1221–31.  https://doi.org/10.1007/s10815-015-0528-9.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Uzelac PS, Delaney AA, Christensen GL, Bohler HC, Nakajima ST. Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years. Fertil Steril. 2015;104(5):1258–60.  https://doi.org/10.1016/j.fertnstert.2015.07.1148.CrossRefPubMedGoogle Scholar
  21. 21.
    Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod. 2001;16(4):632–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7(6):535–43.CrossRefPubMedGoogle Scholar
  23. 23.
    Fadini R, Dal Canto MB, Mignini Renzini M, Brambillasca F, Comi R, Fumagalli D, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod BioMed Online. 2009;19(3):343–51.CrossRefPubMedGoogle Scholar
  24. 24.
    Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005;353(3):318–21.  https://doi.org/10.1056/NEJMc055237.CrossRefPubMedGoogle Scholar
  25. 25.
    Meirow D, Ra’anani H, Biderman H. Ovarian tissue cryopreservation and transplantation: a realistic, effective technology for fertility preservation. Methods Mol Biol. 2014;1154:455–73.  https://doi.org/10.1007/978-1-4939-0659-8_21.CrossRefPubMedGoogle Scholar
  26. 26.
    Revel A, Safran A, Benshushan A, Shushan A, Laufer N, Simon A. In vitro maturation and fertilization of oocytes from an intact ovary of a surgically treated patient with endometrial carcinoma: case report. Hum Reprod. 2004;19(7):1608–11.CrossRefPubMedGoogle Scholar
  27. 27.
    Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian RC, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod BioMed Online. 2010;21(4):566–71.  https://doi.org/10.1016/j.rbmo.2010.05.003.CrossRefPubMedGoogle Scholar
  28. 28.
    Yin H, Jiang H, Kristensen SG, Andersen CY. Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue. J Assist Reprod Genet. 2016;33(6):741–6.  https://doi.org/10.1007/s10815-016-0691-7.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Walls ML, Douglas K, Ryan JP, Tan J, Hart R. In-vitro maturation and cryopreservation of oocytes at the time of oophorectomy. Gynecol Oncol Rep. 2015;13:79–81.  https://doi.org/10.1016/j.gore.2015.07.007.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Sonigo C, Simon C, Boubaya M, Benoit A, Sifer C, Sermondade N, et al. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation? Hum Reprod. 2016;31(7):1493–500.  https://doi.org/10.1093/humrep/dew102.CrossRefPubMedGoogle Scholar
  31. 31.
    Chung K, Donnez J, Ginsburg E, Meirow D. Emergency IVF versus ovarian tissue cryopreservation: decision making in fertility preservation for female cancer patients. Fertil Steril. 2013;99(6):1534–42.  https://doi.org/10.1016/j.fertnstert.2012.11.057.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Alon Kedem
    • 1
  • Gil M. Yerushalmi
    • 1
  • Masha Brengauz
    • 1
  • Hila Raanani
    • 1
  • Raoul Orvieto
    • 1
  • Ariel Hourvitz
    • 1
  • Dror Meirow
    • 1
  1. 1.IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer, and Sackler School of MedicineTel Aviv UniversityTel AvivIsrael

Personalised recommendations